PI
LLY icon

PEAK6 Investments’s Eli Lilly LLY Stock Holding History

PEAK6 Investments’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$62.5M Sell
70,600
-4,700
-6% -$4.23M 0.14% 122
2024
Q2 		$68.2M Buy
75,300
+21,600
+40% +$17.3M 0.18% 92
2024
Q1 		$41.8M Buy
53,700
+50,300
+1,479% +$35.8M 0.11% 144
2023
Q4 		$1.98M Sell
3,400
-2,900
-46% -$1.69M 0.01% 1522
2023
Q3 		$3.38M Buy
6,300
+1,000
+19% +$515K 0.02% 973
2023
Q2 		$2.49M Sell
5,300
-59,000
-92% -$24.7M 0.01% 1066
2023
Q1 		$22.1M Buy
64,300
+1,500
+2% +$506K 0.11% 169
2022
Q4 		$23M Sell
62,800
-17,700
-22% -$6.28M 0.13% 140
2022
Q3 		$26M Buy
80,500
+7,000
+10% +$2.22M 0.11% 163
2022
Q2 		$24.6M Buy
73,500
+54,500
+287% +$16.4M 0.05% 398
2022
Q1 		$5.44M Sell
19,000
-8,200
-30% -$2.11M 0.01% 1047
2021
Q4 		$7.51M Sell
27,200
-22,700
-45% -$5.75M 0.02% 885
2021
Q3 		$11.5M Buy
49,900
+37,000
+287% +$9.13M 0.03% 641
2021
Q2 		$2.96M Sell
12,900
-10,900
-46% -$2.19M 0.01% 1521
2021
Q1 		$4.45M Sell
23,800
-7,800
-25% -$1.53M 0.01% 1149
2020
Q4 		$5.33M Buy
31,600
+8,900
+39% +$1.33M 0.01% 1029
2020
Q3 		$3.36M Buy
22,700
+800
+4% +$124K 0.01% 1243
2020
Q2 		$3.6M Buy
21,900
+15,300
+232% +$2.35M 0.01% 1030
2020
Q1 		$916K Sell
6,600
-13,700
-67% -$1.88M 0.01% 1607
2019
Q4 		$2.67M Sell
20,300
-4,500
-18% -$522K 0.01% 922
2019
Q3 		$2.77M Sell
24,800
-36,900
-60% -$4.11M 0.02% 1064
2019
Q2 		$6.84M Sell
61,700
-17,200
-22% -$2.03M 0.05% 528
2019
Q1 		$10.2M Buy
78,900
+38,700
+96% +$4.71M 0.06% 360
2018
Q4 		$4.65M Sell
40,200
-186,400
-82% -$20.8M 0.03% 687
2018
Q3 		$24.3M Buy
+226,600
New +$22.7M 0.11% 184

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

PEAK6 Investments's LLY Position: Q3 2024 in Review

PEAK6 Investments reduced its Eli Lilly (LLY) stake by 50% in Q3 2024, selling an estimated $899 and leaving 1 share worth $603. The position accounts for ﹤0.01% of the portfolio, ranked #3374.

PEAK6 Investments first reported a position in LLY in Q2 2021 and has held it in 11 quarters since. The position peaked at $6.09M in Q1 2023. 3,657 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

  • PEAK6 Investments held 1 share of Eli Lilly worth $603 as of Q3 2024.
  • PEAK6 Investments sold 1 Eli Lilly share in Q3 2024, an estimated $899.
  • Eli Lilly made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3374 holding.
  • PEAK6 Investments first reported a position in Eli Lilly in Q2 2021 and has held it in 11 quarters since.
  • PEAK6 Investments's Eli Lilly position peaked at $6.09M in Q1 2023.
  • 3,657 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.